• About Us
  • Tumor Hypoxia
  • Clinical Pipeline
    • Soft Tissue Sarcoma
    • Pancreatic Cancer
    • Hematological Malignancies
    • Antiangiogenics
    • [18F]HX4 Hypoxia PET Imaging
  • Investors
    • News Releases
    • Webcasts
    • SEC Filings
    • Corporate Governance
    • Annual Reports
    • Investor FAQ
    • Email Alerts
    • Contact Information
  • News & Resources
    • Scientific Presentations & Publications
  • Careers
    • Current Opportunities
Threshold Pharmaceuticals
About Us

Board of Directors

  • Jeffrey W. Bird, M.D., Ph.D.
    Managing Director, Sutter Hill Ventures, Inc.


  • Bruce C. Cozadd
    Chairman and Chief Executive Officer, Jazz Pharmaceuticals plc


  • David R. Hoffmann
    Chief Executive Officer, Hoffmann Associates


  • Wilfred E. Jaeger, M.D.
    Partner, Three Arch Partners


  • George G. C. Parker, Ph.D.
    Dean Witter Distinguished Professor of Finance and Management,
    Graduate School of Business,
    Stanford University


  • David R. Parkinson, M.D.
    Venture Partner, New Enterprise Associates


  • Harold E. Selick, Ph.D.
    Chief Executive Officer, Threshold Pharmaceuticals, Inc.


  • Management Team
  • Board of Directors

 

Copyright 2004 Threshold Pharmaceuticals   Disclaimer  |  Privacy
Home   Contact   Directions   Site Map    Search